Source information from Chicago Cornea Consultants (United States)

Chicago Cornea Consultants (United States): /resources/treatment-information/corneal-cross-linking-faq/

chicagocornea.com

Read the original source

Where this source is used

1 publication
  1. Chicago Cornea Consultants (United States)

    Company knowledgeUpdated

    Chicago Cornea Consultants (United States) is a company in Chicago, United States.

    • What is keratoconus?

      “Keratoconus is a non-inflammatory eye condition in which the typically dome-shaped cornea progressively thins and weakens, causing the development of a cone-like bulge and optical irregularity of the cornea. This progressive change in the shape of the corneal causes visual disturbance.”

      View in the company profile
    • What is cross-linking?

      “Cross-linking is a minimally invasive, FDA approved, outpatient procedure that combines the use of prescription eye drops, Photrexa® Viscous(riboflavin5’-phosphate in 20% dextran ophthalmic solution), Photrexa® (riboflavin 5’-phosphate ophthalmic solution), and ultra-violet A (UVA) light from the KXL® system for the treatment of progressive keratoconus.”

      View in the company profile
    • What can I expect during the procedure?

      “After numbing drops are applied, the epithelium (the thin layer on the surface of the cornea) is gently removed. Next Photrexa Viscous eye drops will be applied to the cornea for at least 30 minutes. The cornea is then exposed to UV light for 30 minutes while additional Photrexa Viscous drops are applied.”

      View in the company profile
    • What is ultra-violet A (UVA) light?

      “UVA is one of the three types of invisible light rays given off by the sun (together with ultra-violet B and ultra-violet C) and is the weakest of the three.”

      View in the company profile